By Stephen Nakrosis
Shares of Mangoceuticals were trading higher in the after-hours market following news the company acquired a patent for mushroom-derived compositions and methods of treatment.
After the bell, the company's shares were trading 22% higher at $3.06. The stock lost under 1% in Thursday's regular session, closing at $2.44.
Mangoceuticals, which develops men's health and wellness products, said it plans to leverage this patent to research and develop a new line of wellness products.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 19, 2024 18:31 ET (23:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.